npj Genomic Medicine

Aims & Scope

npj Genomic Medicine considers research that explores all aspects of genomics and its application in medicine. The studies we publish can be of individual case studies, families, or populations. The journal covers a broad range of topics including but not limited to: Integrative phenotype and genome data and analysis, including immunogenomics, pharmacogenomics, microbiomics, and system medicine Disease-specific polymorphisms Disease- and aging-related epigenetics and epigenomics Germline and de novo mutations, including point mutations, indels, and copy-number alterations Data mining and artificial intelligence Disease-related alterations to the 3D genome New technologies and informatics Clinical recommendations and/or guidelines of how that data should be used in the clinical management of patients Clinical studies of utility and outcomes in patients receiving genomic medicine Learning healthcare systems related to genomic medicine The journal offers more choice to Nature Portfolio authors who are seeking a fully open-access and more inclusive platform for publishing their work. The journal is led by genomic medicine experts who collaborate to cultivate high-quality research. As part of the npj Series , this journal focuses on fostering global partnerships with the research community and other Springer Nature journals.

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification